Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens
New proprietary formula for the symptomatic relief of pain and irritated sore throat
Initial launch in 3,500 pharmacies in Greece with plans to expand to the UK, Germany, the Netherlands, France, Italy, Spain, Cyprus, Canada and the Middle East
CHICAGO, April 08, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, announced today that it has launched Mosept-Oral, a new, proprietary oral antiseptic spray designed to be effective against bacteria, certain viruses and fungi, as well as for the symptomatic relief of painful, irritated sore throats.
The product is being placed in 3,500 pharmacies and the Company expects to have it in 10,000 pharmacies by the end of the year in Greece. The Company has also started the registration process for Mosept-Oral for the UK with the submission of the documentation for the formulation. It will be gradually registering the product to other countries with local exclusive distributors and expects the registration period to take anywhere from 8-12 months. Initial target countries are the United Kingdom, Germany, the Netherlands, France, Italy, Spain, Cyprus, Canada and the Middle East.
The mouth spray was formulated, designed and developed entirely by the Cosmos Holdings research and development team. Mosept-Oral is made with the highest quality materials and to the highest possible standards, which are, in turn, based on strict pharmaceutical standards and good manufacturing processes (GMP) protocols; these protocols are similar to FDA regulations in the USA. Each ml of Mosept-Oral contains 2 mg of Chlorhexidine digluconate (Chlorhexidine) and 0.5 mg of Lidocaine hydrochloride. Chlorhexidine is a bisbiguanide antiseptic and disinfectant which is bactericidal or bacteriostatic against a wide range of Gram-positive and Gram-negative bacteria and inhibits the proliferation of certain viruses and fungi. Lidocaine is a local anesthetic and impairs the generation and conduction of the nerve impulses by slowing depolarization.